Natural surfactant for prevention and treatment of IRDS
Natural surfactant for the treatment of RDS
- Phospholipid fraction from bovine lungs
- Prevention of respiratory distress syndrome (RDS) in premature infants
- Treatment of infantile respiratory distress syndrome (IRDS)
Pharmaceutical form and presentations
- Lyophilized phospholipids in vials with 50 mg and 100 mg
- Syringe with solvent for reconstitution
- Intratracheal instillation
- Storage at room temperature
- European Union
- On request
Regulatory status, indications and product information may vary from country to country.
Product descriptions provide basic information and are not usage instructions.
Please observe the officially approved product information.